Rapid desensitisation for desferrioxamine anaphylactic reaction.

Suppr

超能文献

作者信息

Miller K B, Rosenwasser L J, Bessette J A, Beer D J, Rocklin R E

出版信息

Lancet. 1981 May 9;1(8228):1059. doi: 10.1016/s0140-6736(81)92227-3.

DOI:10.1016/s0140-6736(81)92227-3

PMID:6112440

Abstract

摘要

相似文献

Rapid desensitisation for desferrioxamine anaphylactic reaction.

Lancet. 1981 May 9;1(8228):1059. doi: 10.1016/s0140-6736(81)92227-3.

Rapid desensitisation for desferrioxamine anaphylactoid reaction.去铁胺类过敏反应的快速脱敏治疗。

Lancet. 1983 Oct 8;2(8354):859-60. doi: 10.1016/s0140-6736(83)90785-7.

Modified desensitization protocols for a pediatric patient with anaphylactic reaction to deferoxamine.

J Med Assoc Thai. 2014 Aug;97 Suppl 8:S217-22.

Anaphylactic reaction to desferrioxamine.对去铁胺的过敏反应。

Lancet. 1977 Sep 17;2(8038):616. doi: 10.1016/s0140-6736(77)91473-8.

[Rapid desensitization for anaphylactoid reactions to desferrioxamine].[去铁胺类过敏样反应的快速脱敏治疗]

Arch Pediatr. 1994 Oct;1(10):959.

Desensitization treatment for anaphylactoid reactions to desferrioxamine in a pediatric patient with thalassemia.一名地中海贫血患儿对去铁胺类过敏反应的脱敏治疗。

J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):127-8. doi: 10.1016/s0091-6749(96)70291-9.

Successful desensitization of a case with desferrioxamine hypersensitivity.用去铁胺超敏反应成功脱敏一例

Minerva Pediatr. 2006 Dec;58(6):571-4.

Successful desensitization of a child with desferrioxamine hypersensitivity.成功使一名对去铁胺过敏的儿童脱敏。

J Investig Allergol Clin Immunol. 1995 Sep-Oct;5(5):294-5.

Successful desensitization to imiglucerase of an adult patient diagnosed with type I Gaucher disease.成功对诊断为 I 型戈谢病的成年患者进行伊米苷酶脱敏。

Int Arch Allergy Immunol. 2013;160(2):215-7. doi: 10.1159/000339754. Epub 2012 Sep 25.

Management and successful desensitization in methotrexate-induced anaphylaxis.甲氨蝶呤诱导的过敏反应的管理与成功脱敏

Pediatr Blood Cancer. 2009 Feb;52(2):295-7. doi: 10.1002/pbc.21742.

引用本文的文献

The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.天然和合成螯合剂在医学中的重要性和必要性：有效治疗铁过载和缺铁症的前景增加。

Int J Mol Sci. 2024 Apr 25;25(9):4654. doi: 10.3390/ijms25094654.

Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.甲磺酸去铁胺用于治疗依赖输血的地中海贫血患者的输血性铁过载。

Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004450. doi: 10.1002/14651858.CD004450.pub3.

Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.去铁酮治疗地中海贫血及其他病症铁过载的获益与风险：与去铁胺的流行病学及治疗学方面比较

Drug Saf. 2003;26(8):553-84. doi: 10.2165/00002018-200326080-00003.

A risk-benefit assessment of iron-chelation therapy.铁螯合疗法的风险效益评估。

Drug Saf. 1997 Dec;17(6):407-21. doi: 10.2165/00002018-199717060-00006.

High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.高剂量去铁胺疗法治疗一名患有获得性再生障碍性贫血和输血性铁过载的女性患者。

Blut. 1986 Apr;52(4):211-9. doi: 10.1007/BF00321080.

Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.在使用Ca-DTPA治疗期间去铁胺诱导的听觉神经毒性的逆转。

Arch Dis Child. 1989 Jan;64(1):77-82. doi: 10.1136/adc.64.1.77.

Deferoxamine (desferrioxamine). New toxicities for an old drug.去铁胺（去铁敏）。一种老药的新毒性。

Drug Saf. 1991 Jan-Feb;6(1):37-46. doi: 10.2165/00002018-199106010-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验